DE69426270T2 - Hgh-rh(1-29)nh2 analoge mit antagonistischer aktivität - Google Patents
Hgh-rh(1-29)nh2 analoge mit antagonistischer aktivitätInfo
- Publication number
- DE69426270T2 DE69426270T2 DE69426270T DE69426270T DE69426270T2 DE 69426270 T2 DE69426270 T2 DE 69426270T2 DE 69426270 T DE69426270 T DE 69426270T DE 69426270 T DE69426270 T DE 69426270T DE 69426270 T2 DE69426270 T2 DE 69426270T2
- Authority
- DE
- Germany
- Prior art keywords
- hgh
- analog
- antagonistic activity
- antagonistic
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000003042 antagnostic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/168,810 US5550212A (en) | 1993-12-17 | 1993-12-17 | Analogues of hGH-RH(1-29)NH2 having antagonistic activity |
PCT/US1994/013714 WO1995016707A1 (en) | 1993-12-17 | 1994-11-28 | ANALOGUES OF hGH-RH (1-29)NH2 HAVING ANTAGONISTIC ACTIVITY |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69426270D1 DE69426270D1 (de) | 2000-12-14 |
DE69426270T2 true DE69426270T2 (de) | 2001-07-05 |
Family
ID=22613022
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69426270T Expired - Fee Related DE69426270T2 (de) | 1993-12-17 | 1994-11-28 | Hgh-rh(1-29)nh2 analoge mit antagonistischer aktivität |
Country Status (13)
Country | Link |
---|---|
US (1) | US5550212A (de) |
EP (1) | EP0734396B1 (de) |
JP (1) | JPH09506616A (de) |
AU (1) | AU695315B2 (de) |
CA (1) | CA2178218A1 (de) |
DE (1) | DE69426270T2 (de) |
DK (1) | DK0734396T3 (de) |
ES (1) | ES2152380T3 (de) |
GR (1) | GR3035170T3 (de) |
NZ (1) | NZ277926A (de) |
PT (1) | PT734396E (de) |
WO (1) | WO1995016707A1 (de) |
ZA (1) | ZA949641B (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5792747A (en) * | 1995-01-24 | 1998-08-11 | The Administrators Of The Tulane Educational Fund | Highly potent agonists of growth hormone releasing hormone |
US5942489A (en) * | 1996-05-03 | 1999-08-24 | The Administrators Of The Tulane Educational Fund | HGH-RH(1-29)NH2 analogues having antagonistic activity |
AU768516B2 (en) * | 1998-06-03 | 2003-12-18 | Ardana Bioscience Limited | Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
US6124263A (en) * | 1998-11-16 | 2000-09-26 | Asta Medica Ag | Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
US6057422A (en) * | 1998-11-25 | 2000-05-02 | The Administrators Of The Tulane Educational Fund | Antagonistic analogs of GH-RH inhibiting IGF-I and -II |
FR2821359B1 (fr) | 2001-02-27 | 2003-05-09 | Sod Conseils Rech Applic | L'heterocarpine, une proteine fixant le ghrh humain |
FR2843697B1 (fr) * | 2002-08-26 | 2005-12-09 | Sod Conseils Rech Applic | L'heterocarpine, une proteine d'origine vegetale aux proprietes anticancereuses |
US7494969B2 (en) | 2002-02-26 | 2009-02-24 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Heterocarpine, a plant-derived protein with anti-cancer properties |
US8691942B2 (en) | 2008-03-28 | 2014-04-08 | University Of Miami | N- and C- terminal substituted antagonistic analogs of GH-RH |
CN107446053A (zh) | 2008-06-12 | 2017-12-08 | 益普生生物创新有限公司 | 癌症的抑制 |
KR101642363B1 (ko) | 2008-06-12 | 2016-07-25 | 입센 바이오이노베이션 리미티드 | 신경내분비계 질환의 억제 |
GB0820970D0 (en) | 2008-11-17 | 2008-12-24 | Syntaxin Ltd | Suppression of cancer |
US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
CA2965696A1 (en) | 2014-11-12 | 2016-05-19 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Treatment of hormonal disorders of growth |
WO2017075535A1 (en) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
AU2020218272A1 (en) | 2019-02-08 | 2021-09-02 | United States Government As Represented By The Department Of Veterans Affairs | Growth hormone-releasing hormone antagonists and uses thereof |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4518586A (en) * | 1983-01-13 | 1985-05-21 | The Salk Institute For Biological Studies | GRF Analogs III |
US4628043A (en) * | 1983-04-26 | 1986-12-09 | The Salk Institute For Biological Studies | Hypothalamic GRF agonists |
US4626523A (en) * | 1983-09-13 | 1986-12-02 | The Salk Institute For Biological Studies | GRF analogs II |
US4528190A (en) * | 1983-10-25 | 1985-07-09 | The Salk Institute For Biological Studies | GRF Analogs IV |
US4659693A (en) * | 1984-04-30 | 1987-04-21 | Syntex (U.S.A.) Inc. | N,N'-dialkyl substituted guanidino amino acyl residue substituted GRF-analog peptides |
FR2567524B1 (fr) * | 1984-07-10 | 1987-11-27 | Sanofi Sa | Procede de synthese de la somatocrinine en phase liquide et peptides intermediaires |
US4649131A (en) * | 1984-09-24 | 1987-03-10 | Hoffmann-La Roche Inc. | Growth hormone releasing factor analogs |
US4622312A (en) * | 1984-09-24 | 1986-11-11 | Hoffmann-La Roche Inc. | Growth hormone releasing factor analogs |
CA1271600A (en) * | 1985-01-07 | 1990-07-10 | David Howard Coy | Growth hormone-releasing peptides and method of treating mammals therewith |
US4689318A (en) * | 1985-08-29 | 1987-08-25 | The Salk Institute For Biological Studies | GRF analogs |
US4880778A (en) * | 1986-05-12 | 1989-11-14 | Eastman Kodak Company | Combinations having synergistic growth hormone releasing activity and methods for use thereof |
US4784987A (en) * | 1987-01-13 | 1988-11-15 | The Salk Institute For Biological Studies | GRF analogs VI |
US4914189A (en) * | 1987-02-05 | 1990-04-03 | The Adminstrators Of The Tulane Educational Fund | Synthetic GHRH analogs |
US4800191A (en) * | 1987-07-17 | 1989-01-24 | Schally Andrew Victor | LHRH antagonists |
US5084555A (en) * | 1989-08-21 | 1992-01-28 | The Administrators Of The Tulane Educational Fund | An octapeptide bombesin analog |
EP0413839A1 (de) * | 1989-08-22 | 1991-02-27 | The Administrators of The Tulane Educational Fund | Analoge von GHRH |
EP0527914A4 (en) * | 1990-05-04 | 1993-08-11 | The Administrators Of The Tulane University Educational Fund | Novel synthetic grf analogs |
JP3051145B2 (ja) * | 1990-08-28 | 2000-06-12 | 住友製薬株式会社 | 新規なポリエチレングリコール誘導体修飾ペプチド |
JP2707938B2 (ja) * | 1993-01-06 | 1998-02-04 | 株式会社ニコン | 発光素子を有するカメラおよび電子閃光装置 |
-
1993
- 1993-12-17 US US08/168,810 patent/US5550212A/en not_active Expired - Fee Related
-
1994
- 1994-11-28 CA CA002178218A patent/CA2178218A1/en not_active Abandoned
- 1994-11-28 DE DE69426270T patent/DE69426270T2/de not_active Expired - Fee Related
- 1994-11-28 PT PT95904767T patent/PT734396E/pt unknown
- 1994-11-28 EP EP95904767A patent/EP0734396B1/de not_active Expired - Lifetime
- 1994-11-28 DK DK95904767T patent/DK0734396T3/da active
- 1994-11-28 WO PCT/US1994/013714 patent/WO1995016707A1/en active IP Right Grant
- 1994-11-28 ES ES95904767T patent/ES2152380T3/es not_active Expired - Lifetime
- 1994-11-28 JP JP7516788A patent/JPH09506616A/ja not_active Ceased
- 1994-11-28 AU AU13322/95A patent/AU695315B2/en not_active Ceased
- 1994-11-28 NZ NZ277926A patent/NZ277926A/en unknown
- 1994-12-05 ZA ZA949641A patent/ZA949641B/xx unknown
-
2000
- 2000-12-29 GR GR20000402857T patent/GR3035170T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NZ277926A (en) | 1997-12-19 |
PT734396E (pt) | 2001-04-30 |
WO1995016707A1 (en) | 1995-06-22 |
DE69426270D1 (de) | 2000-12-14 |
AU1332295A (en) | 1995-07-03 |
DK0734396T3 (da) | 2001-02-12 |
ZA949641B (en) | 1995-08-25 |
GR3035170T3 (en) | 2001-04-30 |
US5550212A (en) | 1996-08-27 |
CA2178218A1 (en) | 1995-06-22 |
JPH09506616A (ja) | 1997-06-30 |
AU695315B2 (en) | 1998-08-13 |
ES2152380T3 (es) | 2001-02-01 |
EP0734396A1 (de) | 1996-10-02 |
EP0734396B1 (de) | 2000-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LV11526A (lv) | Benzodiazepini ar antiaritmiskam ipasibam | |
FI940218A (fi) | Antiparasiittisia aineita | |
DE69421106D1 (de) | Neuronales Netzwerk mit räumlich verteilter Arbeitsweise | |
DE69426270D1 (de) | Hgh-rh(1-29)nh2 analoge mit antagonistischer aktivität | |
DE69932255D1 (de) | Hgh-rh(1-29)nh2 analoge mit antagonistischer aktivität gegen igf-i und -ii | |
DE69333341D1 (de) | Heterologe genexpression in bacillus subtilis: der fusionsansatz | |
EP0611776A3 (de) | Neue antiviral wirksame Pseudopeptide. | |
HU9600519D0 (en) | Substituted 1-amino-3-phenyluracils with herbicidal activity | |
EP0446706A3 (en) | Peptides with tachykinin-agonistic or -antagonistic activity | |
DE59410032D1 (de) | Rollenträger | |
FI960119A (fi) | Peptidit, joilla on oksitosiinin vastaista aktiivisuutta | |
BR9606090A (pt) | Ariltiadiazolonas com atividades herbicida | |
KR950016180U (ko) | 다용도 농작물 지지대 | |
KR950002944U (ko) | 회전구이기 | |
KR950013194U (ko) | 장식대용 회전대 | |
IT237724Y1 (it) | Trasportatore multiuso | |
ATA254093A (de) | Rolloanordnung | |
KR950000076U (ko) | 제빵시스템에서의 소보루 살포장치 | |
KR950017380U (ko) | 칠판의 상, 하 이동장치 | |
KR950019748U (ko) | 그리이스 건 | |
BR6802014U (pt) | Esguicho com articulacao | |
KR940021743U (ko) | 도장기능을 가진 반지 | |
ITMI932153A0 (it) | Peptidi retroinvertiti ad attivita' immunomodulatrice | |
GB9501084D0 (en) | Novel heterocyclic compounds with antitumoral,antiviral,and/or inmunomodulatory activity | |
IL102156A0 (en) | High durability artificial joints |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |